Analysis of relapse rates in pegylated interferon and ribavirin non-responders treated with daily consensus interferon and ribavirin

被引:0
|
作者
Hassanein, Tarek
Ghalib, Reem H.
Zein, Nizar N.
Rothstein, Kenneth D.
Joshi, Shobha N.
Kwo, Paul Yien
Hammond, Janet
机构
[1] Univ Calif San Diego, Ctr Liver, San Diego, CA 92103 USA
[2] Methodist Hosp, Liver Inst, Dallas, TX USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Albert Einstein Ctr Liver Dis, Philadelphia, PA USA
[5] Tulane Univ, New Orleans, LA 70118 USA
[6] Indiana Univ, Indianapolis, IN 46204 USA
[7] Valeant Pharmaceut N Amer, Aliso Viejo, CA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1319
引用
收藏
页码:824A / 824A
页数:1
相关论文
共 50 条
  • [41] Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C - A randomised, controlled pilot study
    Wenger, Christa
    Bischof, Thomas
    Gonvers, Jean-Jacques
    Renner, Eberhard L.
    Mullhaupt, Beat
    SWISS MEDICAL WEEKLY, 2007, 137 (29-30) : 418 - 423
  • [42] Peginterferon alpha-2b plus ribavirin with or without amantidine for the treatment of non-responders to standard interferon and ribavirin
    Hasan, F
    Al-Khaldi, J
    Asker, H
    Al-Ajmi, M
    Owayed, S
    Varghese, R
    Siddique, L
    Al-Nakib, B
    ANTIVIRAL THERAPY, 2004, 9 (04) : 499 - 503
  • [43] TREATMENT OF PEGINTERFERON/RIBAVIRIN NONRESPONDERS WITH DAILY DOSING OF CONSENSUS INTERFERON AND RIBAVIRIN: RESULTS FROM THE GERMAN CONSENSUS INTERFERON MULTICENTER STUDY
    Kaiser, Stephan
    Lutze, Bettina
    Hass, Holger G.
    HEPATOLOGY, 2008, 48 (04) : 1143A - 1143A
  • [44] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [45] Treatment of peginterferon/ribavirin nonresponders with daily dosing of consensus interferon and ribavirin - Preliminary results of the German consensus interferon multicenter study
    Kaiser, Stephan
    Boecher, Wulf
    Schlaak, Joerg F.
    Lutze, Bettina
    Sauter, Birgit
    Bissinger, Lennart
    Werner, Christoph
    Hass, Holger
    Gregor, Michael
    HEPATOLOGY, 2007, 46 (04) : 817A - 817A
  • [46] Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin
    Deltenre, Pierre
    Corouge, Marion
    Canva, Valerie
    Castel, Helene
    Wartel, Faustine
    Dharancy, Sebastien
    Louvet, Alexandre
    Lazrek, Mouna
    Moreno, Christophe
    Henrion, Jean
    Mathurin, Philippe
    JOURNAL OF HEPATOLOGY, 2011, 55 (05) : 989 - 995
  • [47] Soluble interleukin 2 receptor plasma levels in non-responders with chronic hepatitis C treated with pegylated interferon-α 2b and ribavirin
    Henke, H
    Schmiegel, W
    Brechmann, T
    Voigt, E
    Griga, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (03) : 301 - 303
  • [48] Retreatment of standard interferon/ribavirin non-responder patients with chronic hepatitis C with daily consensus interferon and ribavirin yields high sustained response rates.
    Kaiser, S
    Hass, HG
    Gregor, M
    HEPATOLOGY, 2003, 38 (04) : 276A - 276A
  • [49] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [50] Successful treatment with pegylated interferon in HBV non-responders to standard interferon and lamivudine
    Flink, HJ
    Hansen, BE
    van Zonneveld, M
    Schalm, SW
    Janssen, HL
    HEPATOLOGY, 2004, 40 (04) : 663A - 663A